What is ShareRoot?
ShareRoot specializes in leveraging social media and digital tools to create tangible value for businesses, with a particular focus on optimizing real-world evidence to drive advancements in life sciences technologies. The company provides tailored solutions encompassing high-quality content creation, e-commerce enhancement, and bespoke digital marketing strategies, primarily serving the life sciences and health sectors.
By integrating expertise in artificial intelligence and blockchain technology, ShareRoot aims to bolster data security and operational efficiency within medical research. This strategic application of cutting-edge technologies is poised to contribute to the development of personalized medicine, with the ultimate goal of revolutionizing healthcare through the synergy of precision marketing and patient activation, thereby accelerating the introduction of new therapies and clinical practices.
How much funding has ShareRoot raised?
ShareRoot has raised a total of $1.4M across 1 funding round:
Other Financing Round
$1.4M
Other Financing Round (2015): $1.4M with participation from Alexander Gerko, 500.com, Sumit Gupta, and Tim Drees
Key Investors in ShareRoot
500.com
500.com Limited is a leading online sports lottery service provider in China, offering a comprehensive suite of online lottery services and information. Their involvement suggests a strategic interest in technology-driven platforms and potentially diverse market applications.
Alexander Gerko
Alexander Gerko is an investor whose participation indicates confidence in ShareRoot's business model and growth potential within its specialized markets.
Sumit Gupta
Sumit Gupta's investment in ShareRoot points to a belief in the company's innovative approach to digital marketing and its application in the life sciences sector.
What's next for ShareRoot?
With a history of major enterprise-level funding and a recent strategic investment, ShareRoot is well-positioned for significant growth and innovation. The company's focus on merging advanced digital strategies with the critical needs of the life sciences sector suggests a future centered on expanding its AI and blockchain applications for enhanced data security and research efficiency.
Future endeavors will likely involve scaling its operations to meet the increasing demand for its specialized services, potentially exploring new therapeutic areas or expanding its geographical reach. The company's commitment to optimizing real-world evidence and driving personalized medicine indicates a strategic roadmap focused on impactful contributions to healthcare.
